Citadel Advisors’s NEOPHOTONICS CORP NPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-260,595
| Closed | -$4.1M | – | 14254 |
|
|
2022
Q2 | $4.1M | Sell |
260,595
-19,112
| -7% | -$292K | ﹤0.01% | 4166 |
|
|
2022
Q1 | $4.25M | Buy |
279,707
+70,532
| +34% | +$1.07M | ﹤0.01% | 4503 |
|
|
2021
Q4 | $3.21M | Buy |
209,175
+196,384
| +1,535% | +$2.58M | ﹤0.01% | 5196 |
|
|
2021
Q3 | $111K | Sell |
12,791
-39,810
| -76% | -$363K | ﹤0.01% | 12751 |
|
|
2021
Q2 | $537K | Sell |
52,601
-32,299
| -38% | -$341K | ﹤0.01% | 9910 |
|
|
2021
Q1 | $1.01M | Sell |
84,900
-113,004
| -57% | -$1.28M | ﹤0.01% | 8075 |
|
|
2020
Q4 | $1.8M | Sell |
197,904
-98,124
| -33% | -$759K | ﹤0.01% | 5556 |
|
|
2020
Q3 | $1.8M | Buy |
296,028
+273,861
| +1,235% | +$2.09M | ﹤0.01% | 4912 |
|
|
2020
Q2 | $197K | Sell |
22,167
-701,914
| -97% | -$6.05M | ﹤0.01% | 8545 |
|
|
2020
Q1 | $5.25M | Buy |
724,081
+33,422
| +5% | +$248K | ﹤0.01% | 2639 |
|
|
2019
Q4 | $6.09M | Sell |
690,659
-355,364
| -34% | -$2.66M | ﹤0.01% | 2834 |
|
|
2019
Q3 | $6.37M | Buy |
1,046,023
+777,016
| +289% | +$4.37M | ﹤0.01% | 2775 |
|
|
2019
Q2 | $1.13M | Sell |
269,007
-204,982
| -43% | -$1.08M | ﹤0.01% | 5508 |
|
|
2019
Q1 | $2.98M | Sell |
473,989
-222,377
| -32% | -$1.56M | ﹤0.01% | 3771 |
|
|
2018
Q4 | $4.51M | Buy |
696,366
+23,023
| +3% | +$176K | ﹤0.01% | 2931 |
|
|
2018
Q3 | $5.59M | Sell |
673,343
-170,359
| -20% | -$1.3M | ﹤0.01% | 2857 |
|
|
2018
Q2 | $5.26M | Buy |
843,702
+375,432
| +80% | +$2.39M | ﹤0.01% | 2700 |
|
|
2018
Q1 | $3.21M | Sell |
468,270
-575,310
| -55% | -$3.65M | ﹤0.01% | 3050 |
|
|
2017
Q4 | $6.87M | Buy |
1,043,580
+645,820
| +162% | +$3.94M | ﹤0.01% | 2113 |
|
|
2017
Q3 | $2.21M | Buy |
397,760
+20,063
| +5% | +$135K | ﹤0.01% | 3288 |
|
|
2017
Q2 | $2.92M | Buy |
377,697
+67,842
| +22% | +$573K | ﹤0.01% | 2691 |
|
|
2017
Q1 | $2.79M | Buy |
309,855
+105,029
| +51% | +$1.09M | ﹤0.01% | 2671 |
|
|
2016
Q4 | $2.21M | Buy |
204,826
+6,648
| +3% | +$88.6K | ﹤0.01% | 2833 |
|
|
2016
Q3 | $3.24M | Buy |
+198,178
| New | +$2.79M | ﹤0.01% | 2423 |
|
|
2016
Q2 | – | Sell |
-490,196
| Closed | -$6.88M | – | 7592 |
|
|
2016
Q1 | $6.88M | Buy |
490,196
+48,409
| +11% | +$501K | 0.01% | 1498 |
|
|
2015
Q4 | $4.8M | Buy |
441,787
+127,366
| +41% | +$1.15M | 0.01% | 1861 |
|
|
2015
Q3 | $2.14M | Sell |
314,421
-39,870
| -11% | -$309K | ﹤0.01% | 2852 |
|
|
2015
Q2 | $3.23M | Buy |
+354,291
| New | +$2.69M | ﹤0.01% | 2510 |
|
|
2014
Q3 | – | Sell |
-103,760
| Closed | -$432K | – | 8519 |
|
|
2014
Q2 | $432K | Buy |
+103,760
| New | +$549K | ﹤0.01% | 4593 |
|
Other funds holding NPTN
Citadel Advisors's NPTN Position: Q3 2022 in Review
Citadel Advisors sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 260,595 shares — an estimated $4.1M sold.
Citadel Advisors first reported a position in NPTN in Q2 2014 and held it in 29 quarters. The position peaked at $6.88M in Q1 2016. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.
- Citadel Advisors reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
- Citadel Advisors sold 260,595 NEOPHOTONICS CORP shares in Q3 2022, an estimated $4.1M.
- Citadel Advisors first reported a position in NEOPHOTONICS CORP in Q2 2014 and held it in 29 quarters.
- Citadel Advisors's NEOPHOTONICS CORP position peaked at $6.88M in Q1 2016.
- 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.
Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.